Explore the latest news and developments in the San Diego, CA pharmaceutical industry on our dedicated category page. Stay informed about groundbreaking research, innovations in drug development, and key partnerships among biotech companies and pharmaceutical firms. Discover stories highlighting local startups that are making waves in the life sciences sector, as well as updates on clinical trials and regulatory approvals. Our curated content focuses on advancements in pharmaceuticals, biotechnology trends, and the impact of local research institutions on the global healthcare landscape.
In addition to news articles, this category page offers insights into events, conferences, and forums taking place in San Diego that focus on the pharmaceutical sector. Learn about prominent figures and thought leaders in the industry who are shaping the future of medicine and healthcare. Whether you are a healthcare professional, researcher, or simply interested in the pharmaceutical innovations emerging from San Diego, this page serves as your go-to resource for comprehensive coverage and analysis. Keep up with the evolving landscape of pharmaceuticals in one of the country’s leading biotech hubs.
San Francisco, California, January 14, 2026 Sonoma Biotherapeutics has announced a significant workforce reduction in a bid to extend its financial runway and refocus on strategic
San Diego, January 13, 2026 The recent closure of Rampart Bioscience and a 30% workforce reduction at InflaRx N.V. highlight significant challenges in San Diego’s biotechnology
San Diego, January 8, 2026 A class action lawsuit has been filed against Agilon Health, Inc. alleging securities fraud and misleading business practices. The suit focuses
San Diego, January 8, 2026 Eli Lilly and Company has announced its acquisition of San Diego-based Ventyx Biosciences for $1.2 billion. This strategic move aims to
San Diego, January 3, 2026 A new federal bill known as the Biosecure Act mandates that biotech companies in San Diego terminate their relationships with Chinese
San Diego, January 1, 2026 Merck & Co. has announced its acquisition of San Diego-based Cidara Therapeutics for approximately $9.2 billion. This strategic move aims to
San Diego, California, December 20, 2025 Business leaders in San Diego are urging Washington D.C. to prioritize crucial initiatives that foster economic growth in the region.
New York City, USA, December 17, 2025 Pfizer Inc. has forecasted a decline in adjusted profits for 2026, citing falling COVID-19 product sales and revenue losses
San Diego, December 16, 2025 Swedish Orphan Biovitrum AB (Sobi) has announced the acquisition of Arthrosi Therapeutics for up to $1.5 billion. This strategic move aims
San Diego, December 11, 2025 Protego Biopharma has secured an oversubscribed $130 million in Series B financing to advance its lead candidate, PROT-001, for treating AL
